← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 31, 2020Last known activity
Apr 19, 2022
Acquired by Ipsen on Oct 22, 2025
Timeline
2010s
- Jan 1, 2015
ImCheck Therapeutics— Founded
2020s
- Oct 22, 2025
Ipsen— Acquired By
Drugs by trial phase (2 distinct, 2 trials)
Phase 2 (2 own, 0 via acquisition)
Recent trials (5)
- NCT05307874Lead sponsorPhase 1/Phase 2Apr 19, 2022
- NCT05307874Study directorPhase 1/Phase 2Apr 19, 2022
- NCT05307874OfficialPhase 1/Phase 2Apr 19, 2022
- NCT04243499Lead sponsorPhase 1Jan 31, 2020
- NCT04243499Study directorPhase 1Jan 31, 2020
Details
- Founded
- Marseille, FR Jan 1, 2015
- Last known activity
- Apr 19, 2022